{"id":"NCT01785095","sponsor":"IBSA Institut Biochimique SA","briefTitle":"Immunogenicity of Repeated Follicle Stimulating Hormone (FSH) Stimulation Cycles","officialTitle":"Prospective, Open-label, Uncontrolled Clinical Trial Evaluating Multiple Controlled Ovarian Hyperstimulation Cycles in Oocyte Donor, to Assess the Immunogenicity of FSH-IBSA","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-03","primaryCompletion":"2014-07","completion":"2014-11","firstPosted":"2013-02-07","resultsPosted":"2015-03-27","lastUpdate":"2017-02-09"},"enrollment":41,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Oocyte Donation"],"interventions":[{"type":"DRUG","name":"FSH (Follicle Stimulating Hormone)","otherNames":[]}],"arms":[{"label":"FSH","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to evaluate immunogenic potential of FSH-IBSA in healthy volunteers undergoing controlled ovarian hyperstimulation (COH) in an oocyte donation program.","primaryOutcome":{"measure":"Number of Patients Producing Anti-FSH Antibodies.","timeFrame":"4 months.","effectByArm":[{"arm":"Follicle Stimulationg Hormone","deltaMin":0,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":true,"inclusionCount":9,"exclusionCount":11},"locations":{"siteCount":1,"countries":["Spain"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":27},"commonTop":["Headhache","abdominal pain","Pirexia","bacterial vaginosis","candida infection"]}}